← 返回前沿论文

胃癌中幽门螺杆菌感染、错配修复、HER2 与 TIL(肿瘤浸润淋巴细胞)的关联

英文原题:Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer.

查看英文原题

Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer.

PubMed 2024/06/15(内容时间) World J Gastrointest Oncol Q3 · IF 2.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

TIL 水平与 dMMR 和 H 相关。

中文摘要

幽门螺杆菌(H. pylori)感染及胃癌(GC)特征对TIL(肿瘤浸润淋巴细胞)水平的影响尚未得到充分研究。需要分析浸润免疫细胞亚型和生存情况以获得全面信息。

确定错配修复缺陷(dMMR)、HER2状态和H. pylori感染率,并分析其与GC中TIL水平的关系。

纳入503份切除胃癌肿瘤样本,按国际TIL工作组建议评估TIL水平,分别分析瘤内、间质及浸润边缘区。通过免疫组化检测CD3、CD8、CD163免疫细胞密度及dMMR和HER2状态;在部分样本中采用常规组织学和定量PCR评估H. pylori感染。

样本中dMMR占34.4%,HER2阳性占5%,H. pylori阳性占55.7%。瘤内TIL较高与3级分级相关(P=0.038);间质TIL与1级分级(P<0.001)、肠型组织学(P<0.001)及无复发(P=0.003)相关。dMMR与间质区(P=0.019)和浸润边缘区(P=0.01)TIL较高,以及间质CD3(P=0.049)和CD8(P=0.05)密度相关。HER2阴性与瘤内CD8较高相关(P=0.009)。常规组织学检测H. pylori阴性与瘤内TIL高相关(P=0.009);qPCR检测阴性则与三个区室TIL较高(P=0.002至0.047)及瘤内、间质CD8密度较高相关(P=0.001)。较长总生存期与较低瘤内CD163(P=0.003)和CD8/CD3比值(瘤内P=0.001,间质P=0.002),以及较高瘤内CD3(P=0.021)、间质CD3(P=0.003)和CD3/CD163比值(P=0.002)相关。

TIL水平与dMMR及H. pylori阴性相关。较低CD8/CD3和较高CD163/CD3与较少复发及较长生存相关。

展开英文摘要原文

The influence of Helicobacter-pylori ( H. pylori ) infection and the characteristics of gastric cancer (GC) on tumor-infiltrating lymphocyte (TIL) levels has not been extensively studied. Analysis of infiltrating-immune-cell subtypes as well as survival is necessary to obtain comprehensive information. AIM: To determine the rates of deficient mismatch-repair (dMMR), HER2-status and H. pylori infection and their association with TIL levels in GC.

Samples from 503 resected GC tumors were included and TIL levels were evaluated following the international-TILs-working-group recommendations with assessment of the intratumoral (IT), stromal (ST) and invasive-border (IB) compartments. The density of CD3, CD8 and CD163 immune cells, and dMMR and HER2-status were determined by immunohistochemistry (IHC). H. pylori infection was evaluated by routine histology and quantitative PCR (qPCR) in a subset of samples.

dMMR was found in 34.4%, HER2+ in 5% and H. pylori -positive in 55.7% of samples. High IT-TIL was associated with grade-3 ( P = 0.038), while ST-TIL with grade-1 ( P < 0.001), intestinal-histology ( P < 0.001) and no-recurrence ( P = 0.003). dMMR was associated with high TIL levels in the ST ( P = 0.019) and IB ( P = 0.01) compartments, and ST-CD3 ( P = 0.049) and ST-CD8 ( P = 0.05) densities. HER2- was associated with high IT-CD8 ( P = 0.009). H. pylori -negative was associated with high IT-TIL levels ( P = 0.009) when assessed by routine-histology, and with high TIL levels in the 3 compartments ( P = 0.002-0.047) and CD8 density in the IT and ST compartments ( P = 0.001) when assessed by qPCR. A longer overall survival was associated with low IT-CD163 ( P = 0.003) and CD8/CD3 ( P = 0.001 in IT and P = 0.002 in ST) and high IT-CD3 ( P = 0.021), ST-CD3 ( P = 0.003) and CD3/CD163 ( P = 0.002).

TIL levels were related to dMMR and H. pylori -negativity. Low CD8/CD3 and high CD163/CD3 were associated with lower recurrence and longer survival.

论文信息

作者
Castaneda CA、Castillo M、Bernabe LA、Sanchez J、Fassan M、Tello K、Wistuba II、Chavez Passiuri I
第一作者单位
Faculty of Health Sciences, Universidad Cientifica del Sur, Lima 15038, Peru.
通讯作者单位
GECO PERU, Grupo de Estudios Clinicos Oncologicos del Peru, Lima 15038, Peru. ccastaneda@gecoperu.org.
期刊
World journal of gastrointestinal oncology2024 Jun 15
原文标识
PubMed 38994161 · DOI 10.4251/wjgo.v16.i6.2487